Diisopropylethylamine → tert-Butyl 4-((2-isopropylthiazol-4-yl)methyl)piperazine-1-carboxylate
反応式
Cl[CH2:2][C:3]1[N:4]=[C:5]([CH:8]([CH3:10])[CH3:9])[S:6][CH:7]=1.CCN(C(C)C)C(C)C.[C:20]([N:27]1[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]1)([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21]>C(Cl)Cl.CCOC(C)=O>[CH:8]([C:5]1[S:6][CH:7]=[C:3]([CH2:2][N:30]2[CH2:29][CH2:28][N:27]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:32][CH2:31]2)[N:4]=1)([CH3:10])[CH3:9]参加物
反応条件
- 温度
- 35 °C
実験手順
4-(Chloromethyl)-2-isopropyl-thiazole (0.500 g, 2.85 mmol, 1 eq) was suspended in DCM (4.5 mL). DIPEA (1.24 mL, 7.1 mmol, 2.5 eq) was added dropwise, followed by N-Boc-piperazine (1.170 g, 6.3 mmol, 2.2. eq). The reaction mixture was stirred at 35° C. for 5 h, then diluted with EtOAc, and washed with H2O and brine. The organic layer was separated, dried (MgSO4) and the solvent removed in vacuo. The crude product was purified by column chromatography on a Biotage SP1 system (DCM/EtOAc; v/v 1:1) to give the title compound as a clear oil (0.600 g, 65%); 1H-NMR (500 MHz, CDCl3): δ 1.39 (d, J=7.0 Hz, 6H, iPr—CH3), 1.46 (s, 9H, C(CH3)3), 2.47 (br t, J=5.0 Hz, 4H, piperazine N(CH2)2), 3.34 (m, 1H, iPr—CH), 3.6 (br t, J=5.0 Hz, 4H, piperazine N(CH2)2), 3.66 (s, 2H, NCH2), 6.98 (s, 1H, thiazole 5-H); LC (Method B)-MS (ESI, m/z): Rt=2.80 min—326 [(M+H)+, 100%].
後処理
- washwashed with H2O and brine
- customThe organic layer was separated
- dry with materialdried (MgSO4)
- customthe solvent removed in vacuo
- customThe crude product was purified by column chromatography on a Biotage SP1 system (DCM/EtOAc; v/v 1:1)
出典と根拠
- ORDレコード
- ord-35cfde9b68d04fb2828c4ce125075240
- 出典データセット
- uspto-grants-2012_01
- 特許番号
- US08088761B2
反応ノート
読み込み中…